Twist Bioscience Corporation Common Stock
$166.99
$11.43 (+7.35%)
$156.16Day Range$167.05
Key Statistics
Market Cap
$10.31B
Shares Outstanding
66.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 31, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$158.04
Day High
$167.05
Day Low
$156.16
Volume
3.07M
VWAP
$164.28
Prev Close
$155.56
Transactions
--
Acc. Volume
--
About Twist Bioscience Corporation Common Stock
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836979 employees681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080800-719-0671IPO Oct 31, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001581280
- Composite FIGI
- BBG006KDCHJ4
- Share Class FIGI
- BBG006KDCHK2
- Ticker Root
- TWST
- SIC Code
- 2836
About Twist Bioscience Corporation Common Stock (TWST) Stock
Twist Bioscience Corporation Common Stock (TWST) closed the 2026-09-18 session at $166.99, up 7.35% versus the previous close (+11.43). The stock opened at $158.04 and traded between $156.16 and $167.05 during that session. Session trading volume was 3.1M shares. The volume-weighted average price (VWAP) is $164.28.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Twist Bioscience Corporation Common Stock has a market capitalization of $10.31 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. TWST is listed on the XNAS exchange. The company employs approximately 979 people. Twist Bioscience Corporation Common Stock is headquartered in SOUTH SAN FRANCISCO, CA. The recorded listing date is 2018-10-31.
On this page you can find market TWST stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.